AQP9 and fatty liver disease: Oleic acid treatment boosts the p38 phosphorylation, while the inhibition of p38 prevents AQP9 upregulation, suggesting AQP9 as an important player in oleic acid-induced hepatic steatosis in HepG2 cells via p38 signaling [104].